Cargando…

A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease

Mutations in the park2 gene, encoding the RING-inBetweenRING-RING E3 ubiquitin ligase parkin, cause 50% of autosomal recessive juvenile Parkinsonism cases. More than 70 known pathogenic mutations occur throughout parkin, many of which cluster in the inhibitory amino-terminal ubiquitin-like domain, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Spratt, Donald E., Julio Martinez-Torres, R, Noh, Yeong J., Mercier, Pascal, Manczyk, Noah, Barber, Kathryn R., Aguirre, Jacob D., Burchell, Lynn, Purkiss, Andrew, Walden, Helen, Shaw, Gary S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Pub. Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709501/
https://www.ncbi.nlm.nih.gov/pubmed/23770917
http://dx.doi.org/10.1038/ncomms2983
_version_ 1782276759720296448
author Spratt, Donald E.
Julio Martinez-Torres, R
Noh, Yeong J.
Mercier, Pascal
Manczyk, Noah
Barber, Kathryn R.
Aguirre, Jacob D.
Burchell, Lynn
Purkiss, Andrew
Walden, Helen
Shaw, Gary S.
author_facet Spratt, Donald E.
Julio Martinez-Torres, R
Noh, Yeong J.
Mercier, Pascal
Manczyk, Noah
Barber, Kathryn R.
Aguirre, Jacob D.
Burchell, Lynn
Purkiss, Andrew
Walden, Helen
Shaw, Gary S.
author_sort Spratt, Donald E.
collection PubMed
description Mutations in the park2 gene, encoding the RING-inBetweenRING-RING E3 ubiquitin ligase parkin, cause 50% of autosomal recessive juvenile Parkinsonism cases. More than 70 known pathogenic mutations occur throughout parkin, many of which cluster in the inhibitory amino-terminal ubiquitin-like domain, and the carboxy-terminal RING2 domain that is indispensable for ubiquitin transfer. A structural rationale showing how autosomal recessive juvenile Parkinsonism mutations alter parkin function is still lacking. Here we show that the structure of parkin RING2 is distinct from canonical RING E3 ligases and lacks key elements required for E2-conjugating enzyme recruitment. Several pathogenic mutations in RING2 alter the environment of a single surface-exposed catalytic cysteine to inhibit ubiquitination. Native parkin adopts a globular inhibited conformation in solution facilitated by the association of the ubiquitin-like domain with the RING-inBetweenRING-RING C-terminus. Autosomal recessive juvenile Parkinsonism mutations disrupt this conformation. Finally, parkin autoubiquitinates only in cis, providing a molecular explanation for the recessive nature of autosomal recessive juvenile Parkinsonism.
format Online
Article
Text
id pubmed-3709501
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Nature Pub. Group
record_format MEDLINE/PubMed
spelling pubmed-37095012013-07-15 A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease Spratt, Donald E. Julio Martinez-Torres, R Noh, Yeong J. Mercier, Pascal Manczyk, Noah Barber, Kathryn R. Aguirre, Jacob D. Burchell, Lynn Purkiss, Andrew Walden, Helen Shaw, Gary S. Nat Commun Article Mutations in the park2 gene, encoding the RING-inBetweenRING-RING E3 ubiquitin ligase parkin, cause 50% of autosomal recessive juvenile Parkinsonism cases. More than 70 known pathogenic mutations occur throughout parkin, many of which cluster in the inhibitory amino-terminal ubiquitin-like domain, and the carboxy-terminal RING2 domain that is indispensable for ubiquitin transfer. A structural rationale showing how autosomal recessive juvenile Parkinsonism mutations alter parkin function is still lacking. Here we show that the structure of parkin RING2 is distinct from canonical RING E3 ligases and lacks key elements required for E2-conjugating enzyme recruitment. Several pathogenic mutations in RING2 alter the environment of a single surface-exposed catalytic cysteine to inhibit ubiquitination. Native parkin adopts a globular inhibited conformation in solution facilitated by the association of the ubiquitin-like domain with the RING-inBetweenRING-RING C-terminus. Autosomal recessive juvenile Parkinsonism mutations disrupt this conformation. Finally, parkin autoubiquitinates only in cis, providing a molecular explanation for the recessive nature of autosomal recessive juvenile Parkinsonism. Nature Pub. Group 2013-06-17 /pmc/articles/PMC3709501/ /pubmed/23770917 http://dx.doi.org/10.1038/ncomms2983 Text en Copyright © 2013, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Article
Spratt, Donald E.
Julio Martinez-Torres, R
Noh, Yeong J.
Mercier, Pascal
Manczyk, Noah
Barber, Kathryn R.
Aguirre, Jacob D.
Burchell, Lynn
Purkiss, Andrew
Walden, Helen
Shaw, Gary S.
A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
title A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
title_full A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
title_fullStr A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
title_full_unstemmed A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
title_short A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease
title_sort molecular explanation for the recessive nature of parkin-linked parkinson’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709501/
https://www.ncbi.nlm.nih.gov/pubmed/23770917
http://dx.doi.org/10.1038/ncomms2983
work_keys_str_mv AT sprattdonalde amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT juliomartineztorresr amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT nohyeongj amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT mercierpascal amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT manczyknoah amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT barberkathrynr amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT aguirrejacobd amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT burchelllynn amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT purkissandrew amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT waldenhelen amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT shawgarys amolecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT sprattdonalde molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT juliomartineztorresr molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT nohyeongj molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT mercierpascal molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT manczyknoah molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT barberkathrynr molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT aguirrejacobd molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT burchelllynn molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT purkissandrew molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT waldenhelen molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease
AT shawgarys molecularexplanationfortherecessivenatureofparkinlinkedparkinsonsdisease